Forward P/S Multiple: Baird Medical Investment Holdings (BDMD)

Baird Medical - graphic logo of issuer BDMD

Baird Medical Investment (BDMD) maintains a full staff of developers and biomedical specialists while actively expanding its network of sales agents within hospitals. The recruitment of specialized engineers in the microwave ablation niche is driven by competitive bonuses. The projected revenue multiple visualizes market expectation trends, where the 0.00 mark characterizes this parameter. High profitability is sustained through the optimization of electronics supplies for tumor ablation systems.

Baird Medical - BDMD Market Cap to Projected Revenue (period 04/27/2026 - 11/16/2026)

Summary analytical data breakdowns for Baird Medical (BDMD)

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company analysis:BDMD (bairdmed.com)
Product sample of bairdmed.com

Assessing the resilience of the Baird Medical Investment (BDMD) business model requires an analysis of the ratio between current market capitalization and projected revenue, which allows for the verification of market expectations regarding US expansion and the transition to minimally invasive treatment methods. The price action of the expected P/S metric reflects a premium for future sales growth of ablation equipment, where a stable trend confirms the adequacy of the company's valuation relative to its scaling potential.

Who Baird Medical Investment competes with

Price-to-Projected Revenue Ratio Dexcom CGM DXCM|Penumbra Corp (PEN) - Market Cap to Future Revenue Ratio|Novanta Inc - Forward P/S Multiple|HAE (Haemonetics Corporation) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED Inc.) - Forward P/S Multiple|Pulse Corp (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward P/S Multiple picardmedical.com (PMI)|Forward P/S Multiple SRDX (surmodics.com)|Forward P/S Multiple Senseonics Holdings, Inc. SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (Sanuwave Health Inc) - Forward Price-to-Revenue Multiple|Projected Price to Revenue Outset Medical OM|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio LENSAR Inc. LNSR|Price-to-Projected Revenue Ratio AVITA Medical Inc. (RCEL)|Profound Medical Corporation (PROF) - Projected Price to Revenue|EDAP TMS SA - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx LUNG|TELA Bio (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corp.)|Price-to-Projected Revenue Ratio sensushealthcare.com|Forward Price-to-Revenue Multiple Zynex, Inc. (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio inspira-technologies.com IINN|Price to Expected Revenue Ratio ICU (SeaStar Medical Holding Corp.)|IRIX: Forward Price-to-Revenue Multiple|ibs.inc - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Future Price to Revenue PFSA (Profusa Inc.)|Forward Price-to-Revenue Multiple SSKN|Price-to-Projected Revenue Ratio GCTK|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|Venus Concept - Market Cap to Projected Revenue|Forward P/S Multiple NUWE (Nuwellis Corp)|Forward Price to Sales AEMD|ASXC - Price-to-Projected Revenue Ratio|Projected Price to Revenue Avinger, Inc (AVGR)|BSGM: Forward P/S Multiple|Cutera (CUTR) - Forward P/S Multiple|KNW (Know Labs) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Inari Medical (NARI)|Price-to-Projected Revenue Ratio nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical)